Mechanisms of social-stress enhanced allergic airway response in a mouse model

社会压力增强小鼠模型过敏性气道反应的机制

基本信息

  • 批准号:
    8475423
  • 负责人:
  • 金额:
    $ 37.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-15 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic psychosocial stress alters susceptibility to various infectious and inflammatory disorders and enhances the asthmatic airway response. Although hypothalamic-pituitary-adrenal axis activation during stress has long been recognized, the role of endogenous glucocorticoids in regulating the pulmonary immune response remains unclear. Our preliminary studies showed that development of allergic airway inflammation upon inhalation of allergen is protected by homeostatic mechanisms modulating airway dendritic cell function through the lung collectin, surfactant protein D (SP-D). We hypothesize that corticosteroid insensitivity of myeloid dendritic cells (due to cell-type specific impairment of GR expression and abnormal interactions between the GR and NF-?B) mediate the enhancing effects of stress on allergic airway inflammation. Altered GR function attenuates the protective raise in SP-D synthesis in epithelial cells, in response to allergen inhalation. This effect in turn further amplifies dendritic and T cell activation, perpetuating the inflammatory airway response. Aim 1 is to define how stress-induced corticosteroid insensitivity in lung dendritic cells and T cells alter the allergic airway changes in vivo. Using GR agonists, antagonists and CRH-/- mice in a combination of social disruption stress (SDR) and allergic airway inflammation we will test the hypothesis that social stress- induced enhancement of allergic airway inflammation is in part, mediated by corticosteroid insensitive dendritic and/or T cells. By investigating GR and NF-?B expression and DNA binding in corticosterone treated dendritic and T cells, we will define whether corticosteroid insensitivity requires GR downregulation and/or an abnormal NF-?B-GR "tethering". Aim 2 will test the hypotheses that stress attenuates the increase in SP-D transcription in response to allergen challenge and that SP-D protects against development of Th2- type inflammation by inhibiting differentiation and activation of myeloid dendritic cells. By investigating GR, C/EBP and STAT interactions in type II alveolar epithelial cells, we will determine whether stress-induced changes in corticosteroid function affect SP-D transcription. Using conditional SP-D expressor mice we will define if lack of SP-D predisposes to and SP-D over expression protects against the stress-induced enhancement of the allergic airway response. By studying the effects of a recombinant mutant SP-D containing the carbohydrate recognition (CRD), but not the collagen domain, and blocking antibodies against the negative Signal-Regulatory Protein (SIRP) on antigen presenting and Th cell function, we will test the hypothesis that CRD-SIRPa ligation is required for the inhibitory effects of SP-D. Elucidation of the importance of stress-induced impairment of GR and SP-D regulation has great clinical relevance since potentially novel approaches can be devised to control the allergic immune response in the lung.
描述(由申请人提供):慢性心理社会压力改变了对各种感染性和炎症性疾病的易感性,并增强了哮喘的呼吸道反应。虽然人们很早就认识到应激时下丘脑-垂体-肾上腺轴的激活,但内源性糖皮质激素在调节肺免疫反应中的作用仍不清楚。我们的初步研究表明,吸入变应原后过敏性呼吸道炎症的发展受到通过肺集合素、表面活性蛋白D(SP-D)调节气道树突状细胞功能的动态平衡机制的保护。我们推测,髓系树突状细胞对糖皮质激素的不敏感(由于细胞类型特异性的GR表达受损和GR与NF-β之间的异常相互作用)介导了应激对过敏性气道炎症的增强作用。GR功能的改变减弱了上皮细胞中SP-D合成的保护性升高,以应对过敏原吸入。这种效应反过来进一步放大树突状细胞和T细胞的激活,使炎症的呼吸道反应永久化。目的1确定应激诱导的肺树突状细胞和T细胞对糖皮质激素不敏感如何改变体内过敏性呼吸道的变化。使用GR激动剂、拮抗剂和CRH-/-小鼠,在社会破坏应激(SDR)和过敏性气道炎症的组合中,我们将检验这一假说,即社会应激诱导的过敏性气道炎症的增强部分是由皮质类固醇不敏感的树突状细胞和/或T细胞介导的。通过研究皮质酮处理的树突状细胞和T细胞中GR和NF-B的表达和DNA结合,我们将确定皮质类固醇不敏感是否需要GR下调和/或异常的NF-B-GR“拴系”。目的2将验证应激减弱SP-D转录增加以应对变应原攻击的假设,以及SP-D通过抑制髓系树突状细胞的分化和激活而防止Th2型炎症的发展的假设。通过研究肺泡II型上皮细胞中GR、C/EBP和STAT的相互作用,我们将确定应激诱导的皮质类固醇功能改变是否影响SP-D的转录。使用条件性SP-D表达的小鼠,我们将确定是否缺乏SP-D易患过敏性呼吸道反应,而SP-D过度表达可保护应激诱导的过敏性呼吸道反应增强。通过研究含有糖识别(CRD)但不含胶原结构域的重组突变体SP-D对抗原提呈和Th细胞功能的影响,以及阻断针对负信号调节蛋白(SIRP)的抗体对SP-D抑制作用的影响,我们将检验这一假说。阐明应激诱导的GR和SP-D调节受损的重要性具有重要的临床意义,因为可以设计出潜在的新方法来控制肺内的过敏性免疫反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANGELA HACZKU其他文献

ANGELA HACZKU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANGELA HACZKU', 18)}}的其他基金

IND enabling development of LGM2605 as adjuvant treatment for asthma
IND 使 LGM2605 能够开发为哮喘辅助治疗药物
  • 批准号:
    10205985
  • 财政年份:
    2017
  • 资助金额:
    $ 37.25万
  • 项目类别:
Effects of LGM2605 on a Primate Model of Asthma
LGM2605 对灵长类哮喘模型的影响
  • 批准号:
    9347326
  • 财政年份:
    2017
  • 资助金额:
    $ 37.25万
  • 项目类别:
Asthma, anxiety and GR abnormalities in non-human primates
非人类灵长类动物的哮喘、焦虑和 GR 异常
  • 批准号:
    8839569
  • 财政年份:
    2015
  • 资助金额:
    $ 37.25万
  • 项目类别:
Natural Th17 cells in allergic airway disease
天然 Th17 细胞在过敏性气道疾病中的作用
  • 批准号:
    8613435
  • 财政年份:
    2013
  • 资助金额:
    $ 37.25万
  • 项目类别:
Natural Th17 cells in allergic airway disease
天然 Th17 细胞在过敏性气道疾病中的作用
  • 批准号:
    8491276
  • 财政年份:
    2013
  • 资助金额:
    $ 37.25万
  • 项目类别:
Mechanisms of social-stress enhanced allergic airway response in a mouse model
社会压力增强小鼠模型过敏性气道反应的机制
  • 批准号:
    7992922
  • 财政年份:
    2010
  • 资助金额:
    $ 37.25万
  • 项目类别:
Mechanisms of social-stress enhanced allergic airway response in a mouse model
社会压力增强小鼠模型过敏性气道反应的机制
  • 批准号:
    8662158
  • 财政年份:
    2010
  • 资助金额:
    $ 37.25万
  • 项目类别:
Mechanisms of social-stress enhanced allergic airway response in a mouse model
社会压力增强小鼠模型过敏性气道反应的机制
  • 批准号:
    8274810
  • 财政年份:
    2010
  • 资助金额:
    $ 37.25万
  • 项目类别:
Mechanisms of social-stress enhanced allergic airway response in a mouse model
社会压力增强小鼠模型过敏性气道反应的机制
  • 批准号:
    8084157
  • 财政年份:
    2010
  • 资助金额:
    $ 37.25万
  • 项目类别:
Effects of ozone exposure on expression and function of surfactant protein D
臭氧暴露对表面活性蛋白D表达和功能的影响
  • 批准号:
    7941812
  • 财政年份:
    2009
  • 资助金额:
    $ 37.25万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 37.25万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 37.25万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 37.25万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 37.25万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 37.25万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 37.25万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 37.25万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 37.25万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 37.25万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 37.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了